CD274 and non-small cell lung carcinoma: In our previous research, we assessed the impact of PD-L1 expression on tumor cells from patients with unresectable stage III NSCLC who were treated in our institution between 2005 and 2010 in prospective trial with concurrent chemotherapy (ChT) and radiotherapy (RT) [11].